Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,822 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Trilogy Metals stock tanked after a tepid earnings release, shaking confidence in a company that explores copper, gol...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
A couple's early filing case shows how claiming Social Security at 62 can permanently affect a widow's income, unders...
Facing a slide in Micron's stock, investors wonder: why is micron stock still falling? This guide breaks down the mem...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
Institutional investors and hedge funds are quietly shaping the quantum stock landscape. This comprehensive guide bre...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Romance scams can pull at your heart and your wallet. Learn how a former romance scam victim ended up entangled with ...
A forged $5,000 check can slip through a bank’s quick judgments, leaving the victim with bounced funds and a damaged ...